latest news releases from the newsroom
Capital Research Group, Inc
Early Stock Market Alerts for Tuesday, December 14, 2004: DRGG, NVLS, JNPR, BRCD
WESTON, Fla., Dec. 14, 2004 (PRIMEZONE) -- TheSUBWAY.com names the following stocks to its Stock Alerts List: Dragon International Group Corp. (OTCBB:DRGG), Novellus Systems Inc. (Nasdaq:NVLS), Juniper Networks Inc. (Nasdaq:JNPR), Brodcade Communications Systems (Nasdaq:BRCD).
Capital Research Group, Inc
TheSUBWAY.com Announces Its Stock Market Standouts List for Tuesday, December 14, 2004: DRGG, MCHP, AKAM, AMZN
WESTON, Fla., Dec. 14, 2004 (PRIMEZONE) -- TheSUBWAY.com announces the following stocks to its Stock Market Standouts List: Dragon International Group Corp. (OTCBB:DRGG), Microchip Technology Inc. (Nasdaq:MCHP), Akamai Technologies Inc. (Nasdaq:AKAM), Amazon.com Inc. (Nasdaq:AMZN).
Shazamstocks.com Announces Profile Launch of Nighthawk Systems, Inc.
GRANGER, Ind., Dec. 14, 2004 (PRIMEZONE) -- Ken Weiner, Publisher of Shazamstocks.com, today announced profile coverage of Nighthawk Systems, Inc. (OTCBB:NIHK). The Profile is a comprehensive look at Nighthawk Systems, Inc., the company's subsidiaries and products. You can view the complete profile at http://profiles.shaazamstocks.com/nihk/index.htm
PointRoll Technology Powers Online Retail Campaigns This Holiday Season
PHILADELPHIA, Dec. 14, 2004 (PRIMEZONE) -- PointRoll, Inc. (www.pointroll.com), a leading provider of rich media advertising, announced today key performance measurements for the retail sector. PointRoll has served almost one billion impressions within the retail sector across a variety of different customers and has delivered strong results.
Little Rock Foot Clinic Acknowledges the Validity and Enforceability of Cytomedix's Knighton Patent
ROCKVILLE, Md., Dec. 14, 2004 (PRIMEZONE) -- Cytomedix, Inc. (OTCBB:CYME) today announced that on December 8, 2004, the United States District Court for the Northern District of Illinois has entered a consent judgment against Little Rock Foot Clinic, P.A. and its owners, Marvin Cohen, R. Alex Dellinger and Calvin P. Britton, III. In that consent judgment, Little Rock Foot Clinic and its owners admitted that Cytomedix's Knighton patent, which covers the use of compositions containing platelet releasates for wound healing purposes, is valid and enforceable. The Court declared that Little Rock Foot Clinic and its owners had infringed the Knighton Patent and enjoined them, effective immediately and continuing through expiration of the Knighton patent from making, using, offering, or selling within the United States autologous cellular therapies, platelet gel products, or any other processes or products-such as the "SafeBlood Graft(tm)" formulation-that infringe the claims of the Knighton Patent. The Court's injunction is binding on Little Rock Foot Clinic and its owners, and on those acting in concert or participation with them. The Court retained jurisdiction to enforce its order of judgment.